Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr₹-5.48 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹-69 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr
Mar2021₹-114 Cr
Mar2020₹-5.48 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr
Positive
Mar2021 ₹-114 Cr
Negative
Mar2020 ₹-5.48 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,576.1 Cr -0.1% -4% 112.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,744.0 Cr -4.2% -7.7% 24.1% Stock Analytics
DIVIS LABORATORIES ₹152,209.0 Cr -0.6% -5.6% 57.5% Stock Analytics
CIPLA ₹117,762.0 Cr 3.3% -4.8% 6.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,705.3 Cr -2.4% -12.8% 1.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,929.3 Cr -0.3% -2.1% 24.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-0.1%

-4%

112.6%

SENSEX

0.3%

-1.8%

8.6%


You may also like the below Video Courses